About Mitofam
Add Pedigree
Help
About Mitofam
Add Pedigree
Help
MT-COX3
A9972C
A9972C-F1
G9267C
G9267C-F1
G9379A
G9544A
G9804A
G9804A-F3
G9804A-F1
G9907A
G9907A-F1
G9952A
G9952A-F1
G9966A
T9331C
T9478C
T9478C-F2
T9478C-F1
T9789C
T9861C
T9957C
T9957C-F5
T9957C-F3
T9957C-F1
G9553A
Edit by Mitofam Team
-
+
首页
T9789C
# **General Information** | **Position** | **9789** | **Variant** | **m.9789T\>C** | **Locus** | **MT\-CO3** | **Amino\-AcidChange** | **S195P** | | --- | --- | --- | --- | --- | --- | --- | --- | | **Homoplasmy** | \- | **Heteroplasmy** | \+ | **APOGEE2** | Likely\-pathogenic | **Pathogenicity** | Reported | "Pathogenicity" status is derived from published literature or predictions from bioinformatics tools. Researchers and clinicians are cautioned that additional data and/or analysis may still be necessary to confirm the pathological significance of these variants. For more information, please see [Mitofam Info](https://mitofam.com/doc/385/). # **Pedigree Information** The **m.9789T\>C** variant in MT\-CO3 has been reported in 1 pedigree. To date, 1 carrier has been reported. Reported mutation loads ranged from 0% to 50%, with a median of 11\.7% overall; affected carriers showed mutation loads from 0% to 50%, with a median of 11\.7%. In one affected carrier, the mutation was undetectable in blood (0%) and myoblasts (0%) but exceeded 20% in muscle (50%) and sdh\-hyperreactive fibers (43\.5%). The main clinical manifestations among affected carriers included exercise intolerance, elevated lactate, isolated COX deficiency, painful muscle cramps, and rhabdomyolysis with pigmenturia. | **No.** | **Position** | **Variant** | **Family ID** | **Nationality** | **Diseases** | **Unaffected Maternal Relatives** | **Affected Maternal Relatives** | **Publication Year** | **PMID/Ref** | **Note** | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1 | 9789 | m.9789T\>C | T9789C\-F1 | Germany | Exercise intolerance; rhabdomyolysis; isolated COX deficiency | ND | ND | 2005 | [16288875](https://pubmed.ncbi.nlm.nih.gov/16288875/) | | # **Carrier Information** | **No.** | **Position** | **Variant** | **Family ID** | **Carrier ID** | **Type (Fam/De novo/Uninf)** | **Gender (F/M)** | **Proband (Y/N)** | **Affected (Y/N)** | **Die/Alive(D/A)** | **Age** | **Blood Mutant Level** | **Muscle Mutant level** | **Urine Mutant level** | **Other Mutant level** | **Clinical Features** | **Note** | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1 | 9789 | m.9789T\>C | T9789C\-F1 | T9789C\-F1\-P1 | De novo | M | Y | Y | A | 23 | 0% | 50% | / | 0%(myoblasts); 43\.5%(SDH\-hyperreactive fibers); 11\.7%(SDH\-normal fibers) | Exercise intolerance, painful muscle cramps, rhabdomyolysis with pigmenturia, elevated lactate, isolated COX deficiency | | For abbreviations and other usage instructions, please see [Mitofam Info](https://mitofam.com/doc/385/).
Haoying Chen
2026年6月30日 11:24
转发
收藏文档
上一篇
下一篇
手机扫码
复制链接
手机扫一扫转发分享
复制链接
分享
链接
类型
密码
更新密码
有效期
Markdown文件
Word文件
PDF文档
PDF文档(打印)